Published

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: American Journal of Preventive Medicine
Date: 2026-05-03
Source: OpenAlex
DOI: 10.1016/j.amepre.2026.108381
PubMed: 42092643

Authors

Kevin H. Yang Nora Satybaldiyeva Wayne Kepner Joseph Friedman Siyuan Ping Eric C. Leas

Watch author

Topics and keywords

psilocybin Microdosing Clinical Trial Toxicity Clinical Trial MDMA Medicine MEDLINE Psychiatry Young adult Drug Environmental health Epidemiology Cross-sectional study Clinical trial Psychedelics and Drug Studies Forensic Toxicology and Drug Analysis Cannabis and Cannabinoid Research

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults2026-05-03

Related papers

No close related records were found yet.